Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method effector cells using anti-CD127 antibodies for applications in cell therapy

Method effector cells using anti-CD127 antibodies for applications in cell therapy

US Patent 12258577 · Granted Mar 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof2025
Antibodies directed against CD1272025
Antibodies directed against CD1272025
Uses of anti-SIRPg antibodies2025
Uses of anti-SIRPg antibodies2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmen2025
Anti-SIRPa antibodies and their therapeutic applications2025
Anti-SIRPa antibodies and their therapeutic applications2025
Method of promoting a t-cell response or treating cancer by administering an ant2024
Method of promoting a t-cell response or treating cancer by administering an ant2024
Biomarkers for assessing the response status for treatment of Inflammatory condi2024
Antibodies and polypeptides directed against CD1272024